A lab run by blood-testing firm Theranos Inc. in Arizona put patients at risk and failed to quickly fix its deficiencies, a regulator found, triggering a new round of sanctions last month by the U.S. agency against the company. The Centers for Medicare and Medicaid Services imposed its most serious sanctions on the Arizona lab, including a revocation of its U.S. testing license, according to a Jan. 27 letter obtained by The Wall...

Source: Wall Street Journal February 22, 2017 15:00 UTC